Post by
hmmmmmmmm on Oct 17, 2022 4:40pm
"Confirmed"
Confirmed:
Adjective
setteled: rattified
Spectral stated that none of the money raised would be used for Dialco. It was an odd disclosure. Did they incorrectly think that this could somehow alter their need for disclosure of Dialco material information before raising and placing?
The problem of course is they are both under one stock- EDT.
If at a low 40 cents- 30 million shares and options need to be printed for a raise both Spectral and Dialco are effected.
A suppressed price not only takes financial options away from investors, the dilution could remove 10% of the value from shares when it only needed to cost 2 or 3%
Comment by
PezDalatoYou on Oct 17, 2022 5:49pm
The fact that what seems to be the easiest trial ever has not even started and has been delayed by years now. And now no committed funding for the trial either. Did Spectral have any intention at all of starting and completing the DIMI home trial? And how does that tie into tinkering with Spectral's DIMI rights with InfoMed?